Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (998)
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
3,149
Price
$16.85
Total Value
$53.06K
Shares Held After
81,794
% of Holdings
3.7%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
5,836
Price
$2.09
Total Value
$12.20K
Shares Held After
2,775,229
% of Holdings
0.2%
Grace Therapeutics, Inc. (GRCE)
Kohli Prashant — Director
Shares
100,000
Price
$2.14
Total Value
$214.00K
Shares Held After
121,357
% of Holdings
82.4%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
3,097
Price
$68.70
Total Value
$212.78K
Shares Held After
536,876
% of Holdings
0.6%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
28,837
Price
$7.13
Total Value
$205.61K
Shares Held After
3,885,115
% of Holdings
0.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
28,837
Price
$7.13
Total Value
$205.61K
Shares Held After
3,885,115
% of Holdings
0.7%
Vaxcyte, Inc. (PCVX)
Wassil Jim — EVP, Chief Scientific Ofc, COO
Shares
1,334
Price
$59.52
Total Value
$79.40K
Shares Held After
145,435
% of Holdings
0.9%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
36,000
Price
$97.78
Total Value
$3.52M
Shares Held After
708,709
% of Holdings
4.8%
CYBIN INC. (CYBN)
So Eric H. L. — Director
Shares
100,000
Price
$12.39
Total Value
$1.24M
Shares Held After
4,465,014
% of Holdings
2.2%
CYBIN INC. (CYBN)
Glavine Paul — Chief Growth Officer
Shares
100,000
Price
$12.47
Total Value
$1.25M
Shares Held After
4,271,252
% of Holdings
2.3%
CYBIN INC. (CYBN)
Glavine Paul — Chief Growth Officer
Shares
100,000
Price
$12.47
Total Value
$1.25M
Shares Held After
4,271,252
% of Holdings
2.3%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
54,174
Price
$145.87
Total Value
$7.90M
Shares Held After
522,968
% of Holdings
9.4%
Roivant Sciences Ltd. (ROIV)
Fitzgerald Meghan — Director
Shares
20,000
Price
$39.90
Total Value
$798.00K
Shares Held After
42,963
% of Holdings
31.8%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
9,989
Price
$25.03
Total Value
$249.99K
Shares Held After
116,182
% of Holdings
7.9%
Inhibrx Biosciences, Inc. (INBX)
MANHARD KIMBERLY — Director
Shares
500
Price
$115.14
Total Value
$57.57K
Shares Held After
9,500
% of Holdings
5.0%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
371
Price
$212.27
Total Value
$78.75K
Shares Held After
0
% of Holdings
100.0%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
3,844
Price
$211.36
Total Value
$812.46K
Shares Held After
371
% of Holdings
91.2%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
4,730
Price
$210.50
Total Value
$995.68K
Shares Held After
4,215
% of Holdings
52.9%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
2,853
Price
$209.56
Total Value
$597.87K
Shares Held After
8,945
% of Holdings
24.2%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
3,587
Price
$208.55
Total Value
$748.08K
Shares Held After
11,798
% of Holdings
23.3%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
999
Price
$207.33
Total Value
$207.12K
Shares Held After
15,385
% of Holdings
6.1%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
706
Price
$206.60
Total Value
$145.86K
Shares Held After
16,384
% of Holdings
4.1%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Khan Najat — Director
Shares
22,408
Price
$3.52
Total Value
$78.82K
Shares Held After
2,072,890
% of Holdings
1.1%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
6,278
Price
$351.25
Total Value
$2.21M
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
6,569
Price
$350.27
Total Value
$2.30M
Shares Held After
6,278
% of Holdings
51.1%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
10,688
Price
$349.28
Total Value
$3.73M
Shares Held After
12,847
% of Holdings
45.4%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
7,492
Price
$348.31
Total Value
$2.61M
Shares Held After
23,535
% of Holdings
24.1%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
1,721
Price
$348.01
Total Value
$598.93K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
1,517
Price
$347.39
Total Value
$526.99K
Shares Held After
1,721
% of Holdings
46.8%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
2,841
Price
$346.16
Total Value
$983.43K
Shares Held After
3,238
% of Holdings
46.7%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
1,181
Price
$345.38
Total Value
$407.90K
Shares Held After
6,079
% of Holdings
16.3%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
3,442
Price
$23.43
Total Value
$80.66K
Shares Held After
181,641
% of Holdings
1.9%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
14,058
Price
$22.77
Total Value
$320.05K
Shares Held After
185,083
% of Holdings
7.1%
Jazz Pharmaceuticals plc (JAZZ)
GALA RENEE D — President&CEO
Shares
2,000
Price
$243.03
Total Value
$486.06K
Shares Held After
143,394
% of Holdings
1.4%
Korro Bio, Inc. (KRRO)
Dolan Oliver — Senior Vice President, Finance
Shares
7,347
Price
$13.51
Total Value
$99.29K
Shares Held After
16,252
% of Holdings
31.1%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
9,393
Price
$2.10
Total Value
$19.70K
Shares Held After
2,769,393
% of Holdings
0.3%
Metagenomi Therapeutics, Inc. (MGX)
Wein Matthew — General Counsel, Compliance Officer and Corporate Secretary
Shares
358
Price
$1.16
Total Value
$414.71
Shares Held After
126,133
% of Holdings
0.3%
Metagenomi Therapeutics, Inc. (MGX)
Wapnick Pamela — Chief Financial Officer
Shares
1,911
Price
$1.16
Total Value
$2.21K
Shares Held After
206,580
% of Holdings
0.9%
Metagenomi Therapeutics, Inc. (MGX)
Irish Jian — Director
Shares
2,140
Price
$1.16
Total Value
$2.48K
Shares Held After
375,393
% of Holdings
0.6%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
273,290
Price
$10.63
Total Value
$2.90M
Shares Held After
2,298,783
% of Holdings
11.9%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
273,291
Price
$10.63
Total Value
$2.90M
Shares Held After
4,937,026
% of Holdings
5.5%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
48,065
Price
$10.55
Total Value
$507.01K
Shares Held After
2,025,493
% of Holdings
2.3%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
48,066
Price
$10.55
Total Value
$507.02K
Shares Held After
4,663,735
% of Holdings
1.0%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
2,700
Price
$198.09
Total Value
$534.84K
Shares Held After
70,134
% of Holdings
3.7%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
8,752
Price
$197.36
Total Value
$1.73M
Shares Held After
72,834
% of Holdings
10.7%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
6,058
Price
$196.54
Total Value
$1.19M
Shares Held After
81,586
% of Holdings
6.9%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
6,090
Price
$195.62
Total Value
$1.19M
Shares Held After
87,644
% of Holdings
6.5%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
2,400
Price
$194.33
Total Value
$466.40K
Shares Held After
93,734
% of Holdings
2.5%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
2,562
Price
$198.05
Total Value
$507.39K
Shares Held After
26,038
% of Holdings
9.0%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
4,605
Price
$197.23
Total Value
$908.24K
Shares Held After
28,600
% of Holdings
13.9%
Showing 251–300 of 998 transactions (page 6 of 20)